Duchenne Muscular Dystrophy Market: What's More Beyond Exon-Skipping Therapies?
  Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration, primarily affecting young boys. The market for DMD therapeutics has made significant strides in recent years, particularly with the advent of exon-skipping therapies. However, the quest to improve patient outcomes has driven researchers and pharmaceutical companies to explore...
0 Commentarii 0 Distribuiri 245 Views 0 previzualizare
Sponsor